The average Medicare Advantage monthly premium in 2021 will be $21, a 11% decrease from 2020 premiums.
WASHINGTON – CMS announced yesterday its estimated 2021 monthly Medicare Advantage (MA) premiums. According to the agency, the average MA monthly premium in 2021 will be $21, a 11% decrease from 2020 premiums and a 34% reduction from 2017 premiums. In addition, CMS announced that the average number of plan choices per county will increase from 39 plans in 2020 to 47 plans in 2021. Overall, nearly 5000 MA plans will be available across the country in 2021.
CMS also announced that MA enrollment is projected to reach approximately 26.9 million enrollees next year, up from 24.4 million enrollees in 2020. That means that MA will cover 42% of all Medicare beneficiaries.
“America’s seniors are increasingly choosing Medicare Advantage because it delivers better services, better access to care, and better value,” said Matt Eyles, president and CEO of America’s Health Insurance Plans. “And polls show that people in Medicare Advantage are overwhelmingly satisfied with their plan. That’s why we’ll continue to fight for a strong and stable program—both now and in the future.”
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
Community Oncology Reacts to Trump's Drug Pricing Executive Order
May 2nd 2025An executive order signed on Tuesday, March 15, necessitated a change in plans for this panel discussion from the 2025 Community Oncology Conference, with the assembled experts, moderated by Ted Okon, MBA, executive director of the Community Oncology Alliance, speaking to how the order would reverberate across the community oncology space.
Read More
Advancing the Art of Medicine Through Partnership
April 29th 2025Oncology leaders from Alliance Cancer Specialists, American Oncology Network, CHI St. Vincent, Memorial Sloan Kettering Cancer Center, and New York Cancer & Blood Specialists discussed the power of collaboration in cancer care, highlighting partnerships that enhance patient outcomes and resource sharing in community practices.
Read More
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
Community Oncology Reacts to Trump's Drug Pricing Executive Order
May 2nd 2025An executive order signed on Tuesday, March 15, necessitated a change in plans for this panel discussion from the 2025 Community Oncology Conference, with the assembled experts, moderated by Ted Okon, MBA, executive director of the Community Oncology Alliance, speaking to how the order would reverberate across the community oncology space.
Read More
Advancing the Art of Medicine Through Partnership
April 29th 2025Oncology leaders from Alliance Cancer Specialists, American Oncology Network, CHI St. Vincent, Memorial Sloan Kettering Cancer Center, and New York Cancer & Blood Specialists discussed the power of collaboration in cancer care, highlighting partnerships that enhance patient outcomes and resource sharing in community practices.
Read More
2 Commerce Drive
Cranbury, NJ 08512